Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Duclauxin decreases proliferation of tumor cells in vitro and increases the lifespan of mice innoculated with Ehrlich ascitic tumor cells.1,2 Duclauxin (10-30 µg/ml) inhibits mitochondrial respiration of P-388 tumor cells and nucleic acid synthesis in cell culture of Ehrlich cancer, the lymphadenomas NK/LI and L 5178, and sarcoma 37.3,4 Duclauxin also inhibits growth of wheat coleoptile.5,4
WARNING This product is not for human or veterinary use.
1. In vitro effect of duclauxin and derivatives of coumarin on nucleic acid and protein synthesis in Ehrlich’s Ascites Carcinoma cells (EAC). Pharmazie 32(5), 291-293 (1977).
2. Effects of xanthomegnin and duclauxin on culture cells of murine leukemia and Ehrlich ascitic tumor. Res. Commun. Chem. Pathol. Pharmacol. 36(3), 429-438 (1982).
3. Inhibition of mitochondrial functions by the antibiotics, bikaverin and duclauxine. J. Antibiot. (Tokyo) 31(6), 616-620 (1978).
4. The effects of the antibiotics vermiculin PSX-
5. Properties and cost effective method for production of the antitumor agent declauxin from sporulating Penicillium herquei. J. Pharm. Sci. 82(12), 1214-1217 (1993).